Immunosuppression procedure codes
Metadata
- Coding system
- SNOMED CT (UK Clinical Edition)
- Coding system release
- 40.2.0
- Organisation
- NHSD Primary Care Domain Refsets
- Codelist ID
- nhsd-primary-care-domain-refsets/imtrtatrisk1_cod
- Version Tag
- 20250627
- Version ID
- 0fb7cd20
- Number of codes included
- 141
About
Description
Taken from the `IMTRTATRISK1_COD` refset published by NHSD. Contains public sector information licensed under the UK Open Government Licence v3.0 (https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/).
This codelist was imported automatically. The following codes were not found in the SNOMED CT (UK Clinical Edition) dictionary and so excluded from this codelist: 42598211000001107, 42577111000001105, 42652011000001100, 42220011000001101, 42638411000001107.
This may be because this codelist contains both clinical terms and medications. In which case you may need to create another codelist for the missing clinical/medication codes.
References
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
| code | term |
|---|---|
| 106531000119101 | Long-term current use of penicillamine |
| 1141994004 | Rituximab, cyclophosphamide, etoposide, vincristine, prednisone antineoplastic chemotherapy regimen |
| 1148692008 | Radiation therapy following chemotherapy |
| 1149431000000106 | Intraoperative electron radiotherapy |
| 1156505006 | External beam radiation therapy using carbon ions |
| 1156506007 | External beam radiation therapy using photons |
| 1156524009 | Intensity modulated external beam neutron radiation therapy |
| 1156525005 | Mixed beam external beam radiation therapy |
| 1156528007 | External beam radiation therapy using particle spot scanning technique |
| 1156529004 | External beam radiation therapy using particle passive scattering technique |
| 1156667005 | Penicillamine therapy |
| 1156961008 | Chimeric antigen receptor T-cell immunotherapy |
| 1167481000000105 | Intra-arterial injection of antineoplastic agent into bilateral ophthalmic arteries using fluoroscopic guidance with contrast |
| 1172516002 | High-dose chemotherapy with stem cell transplant |
| 1179723002 | Administration of tocilizumab |
| 1179729003 | Administration of sarilumab |
| 12149006 | Chemotherapy administration, subcutaneous, with local anesthesia |
| 1217525002 | Injection of antineoplastic agent into neoplasm of brain tissue |
| 12240661000119103 | Long term systemic steroid user |
| 1254741007 | Intensification antineoplastic therapy regimen |
| 1254742000 | Delayed intensification antineoplastic therapy regimen |
| 1255831008 | Chemotherapy for malignant neoplastic disease using targeted agent |
| 1255834000 | Administration of antineoplastic chemotherapy into peritoneal cavity |
| 1255853005 | Injection of immunotherapeutic agent |
| 1255904006 | Administration of palliative antineoplastic agent |
| 1259200004 | Neoadjuvant antineoplastic chemotherapy |
| 1264382006 | Follow-up for combined therapy of radiation therapy and chemotherapy |
| 1264383001 | Follow-up for combined therapy of surgery and chemotherapy |
| 1264385008 | Follow-up for combined therapy of surgery, radiation therapy, and chemotherapy |
| 1269418000 | Upadacitinib therapy |
| 1269441008 | Ixekizumab therapy |
| 1269442001 | Baricitinib therapy |
| 1269443006 | Belantamab mafodotin therapy |
| 1269444000 | Belatacept therapy |
| 1269445004 | Guselkumab therapy |
| 1287649000 | Cellular immunotherapy |
| 1287683007 | Risankizumab therapy |
| 1287737006 | Sarilumab therapy |
| 1287761004 | Arsenic therapy |
| 1287762006 | Arsenic compound therapy |
| 1290226008 | Administration of antineoplastic agent via intravenous route |
| 1290228009 | Administration of antineoplastic agent via subcutaneous route |
| 15625411000119109 | Long-term current use of apremilast |
| 15625451000119105 | Long-term current use of tofacitinib |
| 16890821000119107 | Long-term current use of ixekizumab |
| 169335009 | External beam radiotherapy with surgery and chemotherapy |
| 169336005 | External beam radiation therapy with chemotherapy |
| 169343004 | Bone marrow suppression using irradiation |
| 169396008 | Radiomimetic chemotherapy |
| 169397004 | Radiochemotherapy by local infiltration |
| 169398009 | Radiochemotherapy: to stop spread |
| 169399001 | Radiochemotherapy via oral route |
| 169400008 | Radiochemotherapy via intravenous route |
| 169402000 | Intraarterial radiochemotherapy |
| 169403005 | Intracavitary radiochemotherapy |
| 171765004 | Intrathecal injection of chemotherapeutic agent |
| 174236121000119109 | Long-term current use of baricitinib |
| 183023001 | Transplant immunosuppression |
| 183651009 | Chemotherapy follow-up |
| 22733003 | Chemotherapy for non-malignant neoplasm |
| 230857009 | Injection of chemotherapeutic substance into subcutaneous reservoir |
| 232681000000103 | Chemotherapy delivery |
| 235331000000103 | Delivery of oral chemotherapy for neoplasm |
| 235391000000102 | Delivery of chemotherapy for neoplasm |
| 238831000000103 | Delivery of exclusively oral chemotherapy for neoplasm |
| 238841000000107 | Delivery of complex chemotherapy for neoplasm including prolonged infusional treatment at first attendance |
| 238851000000105 | Delivery of complex parenteral chemotherapy for neoplasm at first attendance |
| 238861000000108 | Delivery of simple parenteral chemotherapy for neoplasm at first attendance |
| 239071000000100 | Delivery of subsequent element of cycle of chemotherapy for neoplasm |
| 265760000 | Intravenous chemotherapy |
| 265761001 | Intramuscular chemotherapy |
| 265762008 | Subcutaneous chemotherapy |
| 266719004 | Oral chemotherapy |
| 268500004 | Administration of prophylactic chemotherapy |
| 275830000 | Reverse barrier nursing |
| 29391003 | Chemotherapy administration into peritoneal cavity requiring paracentesis |
| 315601005 | Ambulatory chemotherapy |
| 31652009 | Intracavitary chemotherapy for malignant neoplasm |
| 328331000119109 | Pancytopenia caused by non-steroidal anti-inflammatory agent |
| 363688001 | Administration of antineoplastic agent |
| 367336001 | Chemotherapy |
| 38216008 | Infusion chemotherapy for malignant neoplasm |
| 394894008 | Pre-operative chemotherapy |
| 394895009 | Postoperative chemotherapy |
| 394934009 | Combined preoperative chemotherapy and radiotherapy |
| 394935005 | Combined postoperative chemotherapy and radiotherapy |
| 399042005 | Chemotherapy cycle |
| 405165221000119107 | Long-term current use of belantamab mafodotin |
| 4114003 | Parenteral chemotherapy for malignant neoplasm |
| 428501000000108 | [V]Chemotherapy session for neoplasm |
| 450827009 | Induction chemotherapy |
| 483574341000119108 | Long-term current use of upadacitinib |
| 50050141000188100 | Anthracycline therapy |
| 51534007 | Oral chemotherapy for malignant neoplasm |
| 584833311000119102 | Long-term current use of guselkumab |
| 68619000 | Chemotherapy for non-neoplastic disease |
| 6872008 | Perfusion chemotherapy for malignant neoplasm |
| 700496000 | Postoperative administration of antineoplastic agent into peritoneal cavity |
| 703423002 | Combined chemotherapy and radiation therapy |
| 70446004 | Chemotherapy administration into pleural cavity requiring thoracentesis |
| 707311008 | Immunosuppressant drug therapy |
| 713517003 | Infliximab therapy |
| 713518008 | Mycophenolate therapy |
| 713551004 | Azathioprine therapy |
| 716872004 | Antineoplastic chemotherapy regimen |
| 720379009 | Hepatic arterial infusion chemotherapy |
| 721912451000119106 | Long-term current use of risankizumab |
| 722189006 | Abatacept therapy |
| 722472009 | Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen |
| 722482005 | Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy regimen |
| 722491009 | Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen |
| 723945004 | Cyclosporine therapy |
| 724159000 | Rituximab therapy |
| 724160005 | Tacrolimus therapy |
| 724165000 | Tofacitinib therapy |
| 726599006 | Sirolimus therapy |
| 726603006 | Apremilast therapy |
| 7447008 | Immunosuppressive therapy for transplant |
| 762315004 | Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent |
| 782708002 | Everolimus therapy |
| 782710000 | Natalizumab therapy |
| 782711001 | Secukinumab therapy |
| 782712008 | Vedolizumab therapy |
| 816151001 | Administration of consolidation antineoplastic agent |
| 824522871000119100 | History of chimeric antigen receptor T-cell immunotherapy |
| 829591000000101 | Neoadjuvant chemotherapy |
| 830155008 | Administration of hyperthermic antineoplastic agent into peritoneal cavity |
| 830156009 | Administration of hyperthermic antineoplastic agent into thoracic cavity |
| 836671891000119108 | Long-term current use of belatacept |
| 843671000000104 | Electrochemotherapy |
| 860788002 | Ocrelizumab therapy |
| 862921000000106 | Intravesical electrochemotherapy |
| 86553008 | Immunosuppressive therapy |
| 870249004 | Folinic acid, fluorouracil and irinotecan antineoplastic chemotherapy regimen |
| 870250004 | Fluorouracil, leucovorin, irinotecan and oxaliplatin antineoplastic chemotherapy regimen |
| 870253002 | Myeloablative conditioning regimen |
| 87776000 | Intra-arterial infusion of antineoplastic agent |
| 890093004 | Administration of multiple antineoplastic agents |
| 897713009 | Antineoplastic chemoimmunotherapy |
| 950410381000119107 | Immunodeficiency caused by long term therapeutic use of immunosuppressant |
| 968171000000104 | Provision of high dose inhaled corticosteroid safety card |